A Combination of α-Lipoic Acid (ALA) and Palmitoylethanolamide (PEA) Blocks Endotoxin-Induced Oxidative Stress and Cytokine Storm: A Possible Intervention for COVID-19

References

• Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2. doi:10.1016/S2213-2600(20)30076-X.
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–207. doi:10.1056/NEJMoa2001316.
   PubMed Web of Science ®Google Scholar
• Zhu N, Wang W, Liu Z, Liang C, Wang W, Ye F, Huang B, Zhao L, Wang H, Zhou W, et al. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat Commun. 2020;11(1):3910. doi:10.1038/s41467-020-17796-z.
   PubMed Web of Science ®Google Scholar
• Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J. 2020;55(4):2000607. http:// doi:10.1183/13993003.00607-2020.
   PubMed Web of Science ®Google Scholar
• Ahmadpoor P, Rostaing L. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection. Transpl Int. 2020;33(7):824–5. doi:10.1111/tri.13611.
   PubMed Web of Science ®Google Scholar
• Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62–75. doi:10.1016/j.cytogfr.2020.06.001.
   PubMed Web of Science ®Google Scholar
• Wang W, Liu X, Wu S, Chen S, Li Y, Nong L, Lie P, Huang L, Cheng L, Lin Y, et al. Definition and risks of cytokine release syndrome in 11 critically ill COVID-19 patients with pneumonia: analysis of disease characteristics. J Infect Dis. 2020;222(9):1444–51. doi:10.1101/2020.02.26. 20026989.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang C, Huang F, Yang Y, Wang F, Yuan J, Zhang Z, Qin Y, Li X, Zhao D, et al. Novel coronavirus (2019-nCoV) infections trigger an exaggerated cytokine response aggravating lung injury. 2020. http://www.chinaxiv.org/abs/202002.00018.
   Google Scholar
• Chen C, Zhang XR, Ju ZY, He WF. [Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019]. Zhonghua Shao Shang Za Zhi. 2020;36(6):471–5. Chinese. doi:10.3760/cma.j.cn501120-20200224-00088.
   PubMedGoogle Scholar
• Blanco-Melo D, Nilsson-Payant BE, Liu W-C, Uhl S, Hoagland D, Møller R, Jordan TX, Oishi K, Panis M, Sachs D, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181(5):1036–45. doi:10.1016/j.cell.2020.04.026.
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42. doi:10.1001/jama.2020.2648.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–80.e8. doi:10.1016/j.cell.2020.02.052.
   PubMed Web of Science ®Google Scholar
• Chua RL, Lukassen S, Trump S, Henning BP, WEndis D, Pott F, Debnath O, Thurmann, Kurth F, Kazmierski J, et al. Cross-talk between the airway epithelium and activated immune cells defines severity in COVID-19. medRxiv. 2020. doi:10.1101/2020.04.29.20084327.
   Google Scholar
• Jeffers SA, Tusell SM, Gillim-Ross L, Hemmila EM, Achenbach JE, Babcock GJ, Thomas WD, Thackray LB, Young MD, Mason RJ, et al. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci USA. 2004;101(44):15748–53. doi:10.1073/pnas.0403812101.
   PubMed Web of Science ®Google Scholar
• Takayama K. In vitro and animal models for SARS-CoV-2 research. Trends Pharmacol Sci. 2020;41(8):513–7. doi:10.1016/j.tips.2020.05.005.
   PubMed Web of Science ®Google Scholar
• Zhou J, Alvarez-Elizondo MB, Botvinick E, George SC. Local small airway epithelial injury induces global smooth muscle contraction and airway constriction. J Appl Physiol. 2012;112(4):627–37. doi:10.1152/japplphysiol.00739.2011.
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China. N Engl J Med. 2020;382(8):727–33. 2020doi:10.1056/NEJMoa2001017.
   PubMed Web of Science ®Google Scholar
• Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, Sampaziotis F, et al. HCA lung biological network. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681–7. doi:10.1038/s41591-020-0868-6.
   PubMed Web of Science ®Google Scholar
• De Pellegrin ML, Rohrhofer A, Schuster P, Schmidt B, Peterburs P, Gessner A. The potential of herbal extracts to inhibit SARS-CoV-2: a pilot study. Clin Phytosci. 2021;7(1):29. doi:10.1186/s40816-021-00264-6.
   Google Scholar
• Mrityunjaya M, Pavithra V, Neelam R, Janhavi P, Halami P M Ravindra P V., Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19. Front Immunol. 2020;11(570122).
   PubMedGoogle Scholar
• Pagano G, Manfredi C, Pallardó FV, Lyakhovich A, Tiano L, Trifuoggi M. Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia. Inflamm Res. 2021;70(2):159–70. doi:10.1007/s00011-020-01423-0.
   PubMed Web of Science ®Google Scholar
• Lin X, Wang R, Zou W, Sun X, Liu X, Zhao L, Wang S, Jin M. The influenza virus H5N1 infection can induce ROS production for viral replication and host cell death in A549 cells modulated by human Cu/Zn superoxide dismutase (SOD1) overexpression. Viruses. 2016;8(1):13. doi:10.3390/v8010013.
   PubMed Web of Science ®Google Scholar
• Vlahos R, Stambas J, Selemidis S. Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy. Trends Pharmacol Sci. 2012;33(1):3–8. doi:10.1016/j.tips.2011.09.001.
   PubMed Web of Science ®Google Scholar
• Su R, Wang H, Xiao C, Tao Y, Li M, Chen Z. Venetoclax nanomedicine alleviates acute lung injury via increasing neutrophil apoptosis. Biomater Sci. 2021;9(13):4746–54. doi:10.1039/d1bm00481f.
   PubMed Web of Science ®Google Scholar
• McCarty MF, DiNicolantonio JJ, Lerner A. Review - Nutraceuticals can target asthmatic bronchoconstriction: NADPH oxidase-dependent oxidative stress, RhoA and calcium dynamics. J Asthma Allergy. 2021;14:685–701. doi:10.2147/JAA.S307549.
   PubMed Web of Science ®Google Scholar
• Li R-J, Ji W-Q, Pang J-J, Wang J-L, Chen Y-G, Zhang Y. Alpha-lipoic acid ameliorates oxidative stress by increasing aldehyde dehydrogenase-2 activity in patients with acute coronary syndrome. Tohoku J Exp Med. 2013;229(1):45–51. doi:10.1620/tjem.229.45.
   PubMed Web of Science ®Google Scholar
• Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili S-M, Bahreini E. A comprehensive review of COVID-19 characteristics. Biol Proced Online. 2020;22:19. doi:10.1186/s12575-020-00128-2.
   PubMed Web of Science ®Google Scholar
• Morsanuto V, Galla R, Molinari C, Uberti F. A new palmitoylethanolamide form combined with antioxidant molecules to improve its effectivess on neuronal aging. Brain Sci. 2020;10(7):457. doi:10.3390/brainsci10070457.
   PubMed Web of Science ®Google Scholar
• Fusco R, Cordaro M, Genovese T, Impellizzeri D, Siracusa R, Gugliandolo E, Peritore AF, D’Amico R, Crupi R, Cuzzocrea S, et al. Adelmidrol: a new promising antioxidant and anti-inflammatory therapeutic tool in pulmonary fibrosis. Antioxidants (Basel). 2020;9(7):601. doi:10.3390/antiox9070601.
   PubMedGoogle Scholar
• Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, Whitmore A, Heise MT, Baric RS. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio. 2018;9(5):e01753–18. doi:10.1128/mBio.01753-18.
   PubMed Web of Science ®Google Scholar
• Noce A, Albanese M, Marrone G, Di Lauro M, Pietroboni Zaitseva A, Palazzetti D, Guerriero C, Paolino A, Pizzenti G, Di Daniele F, et al. Ultramicronized palmitoylethanolamide (um-PEA): a new possible adjuvant treatment in COVID-19 patients. Pharmaceuticals. 2021;14(4):336. doi:10.3390/ph14040336.
   Web of Science ®Google Scholar
• Thomas G, Frederick E, Hausburg M, Goldberg L, Hoke M, Roshon M, Mains C, Bar-Or D. The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the "cytokine storm" in COVID-19 patients: a hypothesis. Patient Saf Surg. 2020;14:21. doi:10.1186/s13037-020-00248-4.
   PubMed Web of Science ®Google Scholar
• Thorley AJ, Ford PA, Giembycz MA, Goldstraw P, Young A, Tetley TD. Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages. J Immunol. 2007;178(1):463–73. doi:10.4049/jimmunol.178.1.463.
   PubMed Web of Science ®Google Scholar
• Vanderheiden A, Ralfs P, Chirkova T, Upadhyay AA, Zimmerman MG, Bedoya S, Aoued H, Tharp GM, Pellegrini KL, Manfredi C, et al. Type I and Type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures. J Virol. 2020;94(19):e00985-20. doi:10.1128/JVI.00985-20.
   PubMed Web of Science ®Google Scholar
• Kletting S, Barthold S, Repnik U, Griffiths G, Loretz B, Schneider-Daum N, de Souza Carvalho-Wodarz C, Lehr C-M. Co-culture of human alveolar epithelial (hAELVi) and macrophage (THP-1) cell lines. ALTEX. 2018;35(2):211–22. doi:10.14573/altex.1607191.
   PubMedGoogle Scholar
• Molinari C, Morsanuto V, Ghirlanda S, Ruga S, Notte F, Gaetano L, Uberti F. Role of combined lipoic acid and vitamin D3 on astrocytes as a way to prevent brain ageing by induced oxidative stress and iron accumulation. Oxid Med Cell Longev. 2019;2019:2843121. doi:10.1155/2019/2843121.
   PubMed Web of Science ®Google Scholar
• MD Biosciences. LPS-induced lung injury and fibrosis models for COVID-19 therapeutic developments. 2020. https://www.mdbiosciences.com/newsevents/news-archives/lps-induced-lung-injury-and-fibrosis-models-for-covid-19-therapeutic-developments.
   Google Scholar
• Conti P, Ronconi G, Caraffa A, Gallenga C, Ross R, Frydas I, Kritas S. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2):327–31. doi:10.23812/CONTI-E.
   PubMed Web of Science ®Google Scholar
• Grifoni E, Valoriani A, Cei F, Lamanna R, Gelli AMG, Ciambotti B, Vannucchi V, Moroni F, Pelagatti L, Tarquini R, et al. Interleukin-6 as prognosticator in patients with COVID-19. J Infect. 2020;81(3):452–82. doi:10.1016/j.jinf.2020.06.008.
   PubMed Web of Science ®Google Scholar
• Lu L, Zhang H, Dauphars DJ, He Y-W. A potential role of interleukin 10 in COVID-19 pathogenesis. Trends Immunol. 2021;42(1):3–5. doi:10.1016/j.it.2020.10.012.
   PubMed Web of Science ®Google Scholar
• Brandão SCS, Ramos JdOX, Dompieri LT, Godoi ETAM, Figueiredo JL, Sarinho ESC, Chelvanambi S, Aikawa M. Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?Cytokine Growth Factor Rev. 2021;58:102–10. S1359-6101(20)30205-7. doi:10.1016/j.cytogfr.2020.09.002.
   PubMed Web of Science ®Google Scholar
• Chandorkar P, Posch W, Zaderer V, Blatzer M, Steger M, Ammann CG, Binder U, Hermann M, Hörtnagl P, Lass-Flörl C, et al. Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections. Sci Rep. 2017;7(1):11644. doi:10.1038/s41598-017-11271-4.
   PubMedGoogle Scholar
• Jonsdottir HR, Dijkman R. Coronaviruses and the human airway: a universal system for virus-host interaction studies. Virol J. 2016;13:24. doi:10.1186/s12985-016-0479-5.
   PubMed Web of Science ®Google Scholar
• Chua RL, Lukassen S, Trump S, Hennig BP, Wendisch D, Pott F, Debnath O, Thürmann L, Kurth F, Völker MT, et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020;38(8):970–9. doi:10.1038/s41587-020-0602-4.
   PubMed Web of Science ®Google Scholar
• Uberti F, Morsanuto V, Ruga S, Galla R, Farghali M, Notte F, Bozzo C, Magnani C, Nardone A, Molinari C. Study of magnesium formulations on intestinal cells to influence myometrium cell relaxation. Nutrients. 2020;12(2):573. doi:10.3390/nu12020573.
   PubMed Web of Science ®Google Scholar
• Uberti F, Lattuada D, Morsanuto V, Nava U, Bolis G, Vacca G, Squarzanti DF, Cisari C, Molinari C. Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways. J Clin Endocrinol Metab. 2014;99(4):1367–74. doi:10.1210/jc.2013-2103.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhang A, Li N, Li P-L, Zhang F. Concentration-dependent diversifcation effects of free cholesterol loading on macrophage viability and polarization. Cell Physiol Biochem. 2015;37(2):419–31. doi:10.1159/000430365.
   PubMedGoogle Scholar
• Huang K, Li W, Chen Y, Zhu J. Effect of PM2.5 on invasion and proliferation of HeLa cells and the expression of inflammatory cytokines IL-1 and IL-6. Oncol Lett. 2018;16(6):7068–73. doi:10.3892/ol.2018.9516.
   PubMed Web of Science ®Google Scholar
• Hu D-N, Bi M, Zhang DY, Ye F, McCormick SA, Chan C-C. Constitutive and LPS-induced expression of MCP-1 and IL-8 by human uveal melanocytes in vitro and relevant signal pathways. Invest Ophthalmol Vis Sci. 2014;55(9):5760–9. doi:10.1167/iovs.14-14685.
   PubMed Web of Science ®Google Scholar
• Qosa H, Lichter J, Sarlo M, Markandaiah SS, McAvoy K, Richard J-P, Jablonski MR, Maragakis NJ, Pasinelli P, Trotti D, et al. Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis. Glia. 2016;64(8):1298–313. doi:10.1002/glia.23003.
   PubMed Web of Science ®Google Scholar
• De Rudder C, Calatayud Arroyo M, Lebeer S, Van de Wiele T. Dual and triple epithelial coculture model systems with donor-derived microbiota and THP-1 macrophages to mimic host-microbe interactions in the human sinonasal cavities. mSphere. 2020;5(1):e00916-19. doi:10.1128/mSphere.00916-19.
   PubMed Web of Science ®Google Scholar
• Hui DSC, Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical Features. Infect Dis Clin North Am. 2019;33(4):869–89. doi:10.1016/j.idc.2019.07.001.
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4. doi:10.1016/S0140-6736(20)30628-0.
   PubMed Web of Science ®Google Scholar
• Altemimi A, Lakhssassi N, Baharlouei A, Watson DG, Lightfoot DA. Phytochemicals: Extraction, isolation, and identification of bioactive compounds from plant extracts. Plants. 2017;6(4):42. doi:10.3390/plants6040042.
   Web of Science ®Google Scholar
• Tahir A, Javed M, Hussain Z. Nutraceuticals and herbal extracts: A ray of hope for COVID-19 and related infections (Review). Int J Funct Nutr. 2020;1(2):1. doi:10.3892/ijfn.2020.6.
   Google Scholar
• Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585.
   PubMed Web of Science ®Google Scholar
• Sahebnasagh A, Saghafi F, Avan R, Khoshi A, Khataminia M, Safdari M, Habtemariam S, Ghaleno HR, Nabavi SM. The prophylaxis and treatment potential of supplements for COVID-19. Eur J Pharmacol. 2020;887:173530. doi:10.1016/j.ejphar.2020.173530.
   PubMed Web of Science ®Google Scholar
• Subedi L, Tchen S, Gaire BP, Hu B, Hu K. Adjunctive nutraceutical therapies for COVID-19. Int J Mol Sci. 2021;22(4):1963. doi:10.3390/ijms22041963.
   PubMed Web of Science ®Google Scholar
• Carr AC. A new clinical trial to test high-dose vitamin C in patients with COVID-19. Crit Care. 2020;24(1):133. doi:10.1186/s13054-020-02851-4.
   PubMed Web of Science ®Google Scholar
• Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that vitamin D sup- plementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12:E988. doi:10.3390/nu12040988.
   PubMed Web of Science ®Google Scholar
• Lin S-C, Ho C-T, Chuo W-H, Li S, Wang TT, Lin C-C. Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect Dis. 2017;17(1):144. doi:10.1186/s12879-017-2253-8.
   PubMedGoogle Scholar
• Cure E, Cumhur Cure M. Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection. Med Hypotheses. 2020;143:110185. doi:10.1016/j.mehy.2020.110185.
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu Y. Potential interventions for novel coronavirus in China: a systematic review. J Med Virol. 2020;92(5):479–490. doi:10.1002/jmv.25707.
   PubMed Web of Science ®Google Scholar
• Zhong M, Sun A, Xiao T, Yao G, Sang L, Zheng X, Zhang J, Jin X, Xu L, Yang W, Wang P. A randomized, single-blind, group sequential, active-controlled study to evaluate the clinical efficacy and safety of α-lipoic acid for critically ill patients with coronavirus disease 2019 (COVID-19) MEDRXIV. 2020;4. doi:10.1101/2020.04.15.20066266.
   Google Scholar
• Pesce M, Seguella L, Cassarano S, Aurino L, Sanseverino W, Lu J, Corpetti C, Del Re A, Vincenzi M, Sarnelli G, et al. Phytotherapics in COVID19: Why palmitoylethanolamide?Phytother Res. 2020;9. doi:10.1002/ptr.6978.
   Google Scholar
• Esposito G, Capoccia E, Turco F, Palumbo I, Lu J, Steardo A, Cuomo R, Sarnelli G, Steardo L. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation. Gut. 2014;63(8):1300–12. doi:10.1136/gutjnl-2013-305005.
   PubMed Web of Science ®Google Scholar